367 results on '"Jazz Pharmaceuticals"'
Search Results
2. Paclitaxel and Ramucirumab +/- Zanidatamab in HER2 Postive Advanced Gastroesophageal Adenocarcinoma
3. Assessment of Potential for Chronic Liver Injury in Participants Treated With Epidiolex (Cannabidiol) Oral Solution
4. Induction Therapy for Patients With FLT3 Mutated Acute Myeloid Leukemia
5. CPX-351 or CLAG-M Regimen for the Treatment of Acute Myeloid Leukemia or Other High-Grade Myeloid Neoplasms in Medically Less-Fit Patients
6. Lurbinectedin in FET-Fused Tumors (LiFFT)
7. Neoadjuvant Lurbinectedin and Preoperative Radiation for Treating Soft Tissue Sarcomas
8. Study of CPX-351 (VYXEOS) in Individuals < 22 Years With Secondary Myeloid Neoplasms
9. CPX-351 and Glasdegib for Newly Diagnosed Acute Myelogenous Leukemia With MDS Related Changes or Therapy-related Acute Myeloid Leukemia
10. Vyxeos(CPX-351) in Adults w R/R Acute Lymphoblastic Leukemia
11. Disentangling the Role of Depression in Hypersomnia
12. Effect of CBD on the Brain
13. Effect of CANnabidiol on Anxiety and GABAergic Function in Individuals With Fragile-X Syndrome (CANAX)
14. Defibrotide Prophylaxis of Transplant Associated-Thrombotic Microangiopathy for Neuroblastoma
15. Phase II Trial of Lurbinectedin Combined With Avelumab as Switch Maintenance Firstline Therapy
16. Using Ultrasound Elastography to Predict Development of Hepatic Sinusoidal Obstruction Syndrome
17. Phase IB/II of CPX-351 for Relapse Prevention in AML
18. CPX-351 for the Treatment of Secondary Acute Myeloid Leukemia in Patients Younger Than 60 Years Old
19. Vyxeos Plus Gilteritinib in Relapsed or Refractory, FLT3-Mutated AML
20. CPX-351 in Combination With Gemtuzumab Ozogamicin in Newly Diagnosed AML
21. ARISTOCRAT: Blinded Trial of Temozolomide +/- Cannabinoids (ARISTOCRAT)
22. Phase 1b of Lurbinectedin in Combination With Weekly Paclitaxel and Bevacizumab in Platinum-resistant Ovarian Cancer
23. Defibrotide for the Treatment of Severe COVID-19
24. CPX-351 Versus Immediate Stem Cell Transplantation for the Treatment of High-Grade Myeloid Cancers With Measurable Residual Disease
25. Lurbinectedin + Doxorubicin In Leiomyosarcoma
26. Testing the Effect of Taking Ruxolitinib and CPX-351 in Combination for the Treatment of Advanced Phase Myeloproliferative Neoplasms
27. CPX-351 (Vyxeos™) for Transplant Eligible, Higher Risk Patients With Myelodysplastic Syndrome
28. Immune Checkpoint Inhibition With Lurbinectedin Relapsed/Recurrent SCLC
29. Efficacy of Epidiolex in Patients With Electrical Status Epilepticus of Sleep (ESES).
30. Anesthetic Premedication With a Cannabis Extract (Cannapremed) (Cannapremed)
31. Investigator Initiated Trial of CPX-351 for Untreated Acute Myeloid Leukemia
32. Lurbinectedin in Patients With Advanced Gastrointestinal Malignancies With DNA Repair Mutations
33. CPX-351 vs Intensive Chemotherapy in Patients With de Novo Intermediate or Adverse Risk AML Stratified by Genomics (ALFA2101)
34. Palliative Radiotherapy With Lurbinectedin in Patients With Extensive Stage Small Cell Lung Cancer
35. CBDV vs Placebo in Children and Adults up to Age 30 With Prader-Willi Syndrome (PWS)
36. CPX-351 and Gemtuzumab Ozogamicin in Treating Patients With Relapsed Acute Myeloid Leukemia
37. Study of Standard Intensive Chemotherapy Versus Intensive Chemotherapy With CPX-351 in Adult Patients With Newly Diagnosed AML and Intermediate- or Adverse Genetics
38. A Phase IIb Study of Nabiximols for Spasticity Due to Neuromyelitis Optica Spectrum Disorders (SENS-NMO)
39. Delphi Consensus Excessive Daytime Sleepiness in OSA
40. Safety and Tolerability of Cannabidiol in Subjects With Drug Resistant Epilepsy (CBD)
41. CPX-351 Plus Enasidenib for Relapsed AML
42. Neuroimaging and CBD for Opiod Use Disorder
43. Epidiolex in Typical Absence Seizures
44. A Trial of Treatments to Assess the Effects on Outcome of Adults With AML and MDS Undergoing Allogeneic SCT (COSI)
45. Novel Cognitive Treatment Targets for Epidiolex in Sturge- Weber Syndrome
46. Project PEER: Understanding the Lung Cancer Patient ExperiEnce in the Real-World Setting (PEER)
47. Treatment of REM Sleep Behavior Disorder (RBD) With Sodium Oxybate
48. CPX-351+GO in Subjects 55 Years Old, or Older, With AML (CPX GO)
49. Solriamfetol in Binge Eating Disorder
50. CPX-351 Salvage Therapy Followed by Haplo-Cord Transplant for Relapsed/Refractory Leukemia or Myelodysplastic Syndrome
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.